BioAscent is a leading provider of integrated drug discovery services, including:
- de novo assay development
- target analysis and bespoke screening strategies
- compound screening
- medicinal and synthetic chemistry
- computational chemistry and compound management
All with access to a library of 125K lead-like compounds via Compound Cloud.
We’ve worked with BioAscent on deep learning methods to analyse millions of compound bioactivities in order to learn which features of a compound make it active towards different drug targets. Read more >
You can find out more about BioAscent on their website.